title: Profile: VAXIMM.
authors.affiliation: VAXIMM AG; Basel, Switzerland.
authors.forename: Klaus
authors.initials: K
authors.lastname: Breiner
authors.forename: Heinz
authors.initials: H
authors.lastname: Lubenau
mesh_terms: D019496:Cancer Vaccines / Q000276:immunology* / Q000302:isolation & purification*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009389:Neovascularization, Pathologic / Q000517:prevention & control*; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D019496:Cancer Vaccines